| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
1,209 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-1 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Globestar Therapeutics Corporation is a biotechnology company that is focused on developing innovative therapies for neurological diseases and disorders. They are dedicated to advancing research and development in the field of neuroscience with the goal of improving the lives of patients suffering from conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
The company utilizes cutting-edge technologies and scientific insights to identify and develop potential drug candidates that target the underlying causes of these neurological disorders. Their approach involves a combination of drug discovery, preclinical testing, and clinical trials to ensure that their therapies are safe and effective.
Globestar Therapeutics Corporation also collaborates with academic institutions, research organizations, and other industry partners to leverage their expertise and resources. This collaborative approach allows them to tap into a diverse range of scientific knowledge and accelerate the development of their therapies.
Overall, Globestar Therapeutics Corporation is committed to bringing innovative neurological therapies to market and making a positive impact on patients' lives. They aim to address the unmet medical needs in the field of neuroscience and contribute to the advancement of treatments for neurological diseases.
Company Address: 1280 Lexington Ave. New York 10028 NY
Company Phone Number: 531-1671 Stock Exchange / Ticker: GSTC
|
0.000%
